Literature DB >> 1520272

Kinetic analysis of the type-1 proinsulin endopeptidase by a monoclonal antibody-based immunoadsorbent assay.

E M Bailyes1, J C Hutton.   

Abstract

A simple, rapid and sensitive assay for the type-1 endopeptidase (Arg-Arg cleaving) was developed by using an antiproinsulin monoclonal immunoadsorbent to separate reaction products from the substrate. The values obtained by this assay were identical with those obtained by an h.p.l.c.-based procedure and yielded similar values for the pH optimum (5.6) and Ca2+ activation (K0.5 = 2 mM). It was shown that the type-1 endopeptidase was readily solubilized by Triton X-114 (87 +/- 3%, n = 12) and partitioned principally into the aqueous phase at 30 degrees C (90.1 +/- 2.6%, n = 12). Activity was lost on gel filtration, but could be restored by adenosine 5'-[gamma-thio]triphosphate (K0.5 = 6 microM), 50 microM-dithiothreitol or 50 microM-Ca(2+)-trans-1,2-diaminocyclohexane-NNN'N'-tetra-acetic acid (CDTA), indicating that the enzyme was particularly sensitive to heavy metal ions. The Km obtained with proinsulin as substrate (13 +/- 1.7 microM) indicated that the enzyme works at close to its Vmax. in the nascent secretory granule. The Vmax. of the enzyme prepared from insulin granules (0.6% proinsulin converted/min) corresponded closely to the rate measured in vivo in rat islets. The type-1 endopeptidase also appears to be capable of binding to proinsulin in the region of the C-peptide/A-chain junction, since a peptide spanning this region was found to inhibit the 125I-proinsulin processing measured by this assay.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520272      PMCID: PMC1133043          DOI: 10.1042/bj2860223

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Concentration of MgATP2- and other ions in solution. Calculation of the true concentrations of species present in mixtures of associating ions.

Authors:  A C Storer; A Cornish-Bowden
Journal:  Biochem J       Date:  1976-10-01       Impact factor: 3.857

2.  Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes.

Authors:  L Thomas; R Leduc; B A Thorne; S P Smeekens; D F Steiner; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

3.  Isolation and functional expression of a mammalian prohormone processing enzyme, murine prohormone convertase 1.

Authors:  J Korner; J Chun; D Harter; R Axel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans.

Authors:  S P Smeekens; A S Avruch; J LaMendola; S J Chan; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 6.  Post-translational proteolysis in polypeptide hormone biosynthesis.

Authors:  K Docherty; D F Steiner
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

7.  Characterization of PC2, a mammalian Kex2 homologue, following expression of the cDNA in microinjected Xenopus oocytes.

Authors:  K I Shennan; S P Smeekens; D F Steiner; K Docherty
Journal:  FEBS Lett       Date:  1991-06-24       Impact factor: 4.124

8.  Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes.

Authors:  W J van de Ven; J Voorberg; R Fontijn; H Pannekoek; A M van den Ouweland; H L van Duijnhoven; A J Roebroek; R J Siezen
Journal:  Mol Biol Rep       Date:  1990-11       Impact factor: 2.316

9.  Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway.

Authors:  M Hosaka; M Nagahama; W S Kim; T Watanabe; K Hatsuzawa; J Ikemizu; K Murakami; K Nakayama
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

10.  Biochemical and clinical implications of proinsulin conversion intermediates.

Authors:  B D Given; R M Cohen; S E Shoelson; B H Frank; A H Rubenstein; H S Tager
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

View more
  7 in total

1.  Proinsulin processing in the rat insulinoma cell line INS after overexpression of the endoproteases PC2 or PC3 by recombinant adenovirus.

Authors:  J C Irminger; K Meyer; P Halban
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

2.  Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats.

Authors:  Y Nie; M Nakashima; P L Brubaker; Q L Li; R Perfetti; E Jansen; Y Zambre; D Pipeleers; T C Friedman
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

3.  Sequence requirements for proinsulin processing at the B-chain/C-peptide junction.

Authors:  J E Kaufmann; J C Irminger; P A Halban
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

Review 4.  Proinsulin processing in the regulated and the constitutive secretory pathway.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

5.  Differences between the catalytic properties of recombinant human PC2 and endogenous rat PC2.

Authors:  E M Bailyes; K I Shennan; E F Usac; S D Arden; P C Guest; K Docherty; J C Hutton
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

6.  An internally quenched fluorogenic substrate of prohormone convertase 1 and furin leads to a potent prohormone convertase inhibitor.

Authors:  F Jean; A Basak; J DiMaio; N G Seidah; C Lazure
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

7.  pH-independent and -dependent cleavage of proinsulin in the same secretory vesicle.

Authors:  L Orci; P Halban; A Perrelet; M Amherdt; M Ravazzola; R G Anderson
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.